128 related articles for article (PubMed ID: 37123725)
1. The Beauty and the Beast: Bariatric Surgery and a Case of Oxalate Nephropathy.
Carvalho R; Medeiros J; Ribeiro B; Bastos JM; Vaz R
Cureus; 2023 Mar; 15(3):e36801. PubMed ID: 37123725
[TBL] [Abstract][Full Text] [Related]
2. Reversal of Gastric Bypass Resolves Hyperoxaluria and Improves Oxalate Nephropathy Secondary to Roux-en-Y Gastric Bypass.
Agrawal V; Wilfong JB; Rich CE; Gibson PC
Case Rep Nephrol Dial; 2016; 6(3):114-119. PubMed ID: 27781207
[TBL] [Abstract][Full Text] [Related]
3. Oxalate nephropathy complicating Roux-en-Y Gastric Bypass: an underrecognized cause of irreversible renal failure.
Nasr SH; D'Agati VD; Said SM; Stokes MB; Largoza MV; Radhakrishnan J; Markowitz GS
Clin J Am Soc Nephrol; 2008 Nov; 3(6):1676-83. PubMed ID: 18701613
[TBL] [Abstract][Full Text] [Related]
4. Bariatric Surgery in Patients with a History of Nephrolithiasis: 24-h Urine Profiles and Radiographic Changes After Roux-en-Y Gastric Bypass Versus Sleeve Gastrectomy.
Uy M; Di Lena R; Hoogenes J; Alharbi B; Gmora S; Shayegan B; Matsumoto ED
Obes Surg; 2021 Apr; 31(4):1673-1679. PubMed ID: 33387265
[TBL] [Abstract][Full Text] [Related]
5. Reversibility of oxalate nephropathy in a kidney transplant recipient with prior gastric bypass surgery.
Sørensen CG; Hvas CL; Thomsen IM; Jespersen B
Clin Kidney J; 2021 May; 14(5):1478-1480. PubMed ID: 34221374
[TBL] [Abstract][Full Text] [Related]
6. Steatorrhea and hyperoxaluria occur after gastric bypass surgery in obese rats regardless of dietary fat or oxalate.
Canales BK; Ellen J; Khan SR; Hatch M
J Urol; 2013 Sep; 190(3):1102-9. PubMed ID: 23499748
[TBL] [Abstract][Full Text] [Related]
7. Roux-en-Y gastric bypass is associated with early increased risk factors for development of calcium oxalate nephrolithiasis.
Duffey BG; Pedro RN; Makhlouf A; Kriedberg C; Stessman M; Hinck B; Ikramuddin S; Kellogg T; Slusarek B; Monga M
J Am Coll Surg; 2008 Jun; 206(6):1145-53. PubMed ID: 18501812
[TBL] [Abstract][Full Text] [Related]
8. A Friend or a Foe? Bariatric Surgery in Chronic Kidney Disease: A Case Report.
Bagai S; Bansal B; Malik V; Prasad P; Khullar D
Case Rep Nephrol Dial; 2022; 12(3):207-211. PubMed ID: 36465578
[TBL] [Abstract][Full Text] [Related]
9. A case of reversible hyperoxaluria nephropathy early after roux-en-y-gastric bypass induced by vitamin C intake.
Farhat S; Houssam A; Ghassaoui A; Khaled EA; El Khoury M
Oxf Med Case Reports; 2016 Aug; 2016(8):omw054. PubMed ID: 29497551
[TBL] [Abstract][Full Text] [Related]
10. Perforated Duodenal Ulcer Post-Roux-en-Y Gastric Bypass: A Case Report.
Hughes L; Morris M; Que B; Rai G; Jorge J; Tiesenga F
Cureus; 2023 Feb; 15(2):e35112. PubMed ID: 36945278
[TBL] [Abstract][Full Text] [Related]
11. Medical Management of Advanced Oxalate Nephropathy Secondary to Gastric Bypass Surgery.
Kamel TH; Maroz N
Am J Med Sci; 2021 Apr; 361(4):517-521. PubMed ID: 33187632
[TBL] [Abstract][Full Text] [Related]
12. Risk of nephrolithiasis, hyperoxaluria, and calcium oxalate supersaturation increased after Roux-en-Y gastric bypass surgery: a systematic review and meta-analysis.
Upala S; Jaruvongvanich V; Sanguankeo A
Surg Obes Relat Dis; 2016; 12(8):1513-1521. PubMed ID: 27396545
[TBL] [Abstract][Full Text] [Related]
13. Laparoscopic Roux-en-Y gastric bypass in adolescents with severe obesity (AMOS): a prospective, 5-year, Swedish nationwide study.
Olbers T; Beamish AJ; Gronowitz E; Flodmark CE; Dahlgren J; Bruze G; Ekbom K; Friberg P; Göthberg G; Järvholm K; Karlsson J; Mårild S; Neovius M; Peltonen M; Marcus C
Lancet Diabetes Endocrinol; 2017 Mar; 5(3):174-183. PubMed ID: 28065734
[TBL] [Abstract][Full Text] [Related]
14. Comparative effectiveness of 3 bariatric surgery procedures: Roux-en-Y gastric bypass, laparoscopic adjustable gastric band, and sleeve gastrectomy.
Lee JH; Nguyen QN; Le QA
Surg Obes Relat Dis; 2016 Jun; 12(5):997-1002. PubMed ID: 27220823
[TBL] [Abstract][Full Text] [Related]
15. Oxalate nephropathy in a diabetic patient after gastric by-pass.
Moutzouris DA; Skaneli G; Margellos V; Apostolou T; Petraki C; Nikolopoulou N
Clin Nephrol; 2011 Feb; 75 Suppl 1():16-9. PubMed ID: 21269587
[TBL] [Abstract][Full Text] [Related]
16. Gastric band placement for obesity is not associated with increased urinary risk of urolithiasis compared to bypass.
Penniston KL; Kaplon DM; Gould JC; Nakada SY
J Urol; 2009 Nov; 182(5):2340-6. PubMed ID: 19762051
[TBL] [Abstract][Full Text] [Related]
17. Banded Roux-en-Y gastric bypass in patients with super morbid obesity (BRandY-study): protocol of a cohort study with 10 year follow-up.
Romeijn MM; Leclercq WKG; Luijten AAPM; Janssen L; van Dielen FMH
BMC Surg; 2020 Jun; 20(1):122. PubMed ID: 32503510
[TBL] [Abstract][Full Text] [Related]
18. Roux-en-Y gastric bypass surgery induced oxalosis and acute kidney injury: A case report.
Askari Z; Boskabadi J; Kargar-Soleimanabad S; Gholami F
Ann Med Surg (Lond); 2021 Dec; 72():103088. PubMed ID: 34888042
[TBL] [Abstract][Full Text] [Related]
19. Revisional Gastric Bypass for Failed Restrictive Procedures: Comparison of Single-Anastomosis (Mini-) and Roux-en-Y Gastric Bypass.
Almalki OM; Lee WJ; Chen JC; Ser KH; Lee YC; Chen SC
Obes Surg; 2018 Apr; 28(4):970-975. PubMed ID: 29101719
[TBL] [Abstract][Full Text] [Related]
20. Primary Roux-en-Y Gastric Bypass Results in Greater Weight Loss at 15-Year Follow-Up Compared with Secondary Roux-en-Y Gastric Bypass After Failure of Gastric Band or Mason McLean Vertical Gastroplasty.
Etienne JH; Petrucciani N; Goetschy M; Gugenheim J; Schneck AS; Iannelli A
Obes Surg; 2020 Oct; 30(10):3655-3668. PubMed ID: 32488745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
